LHNVD 105
Alternative Names: LHNVD-105Latest Information Update: 02 May 2024
At a glance
- Originator Longhorn Vaccines and Diagnostics
- Class Influenza virus vaccines; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza virus infections
Most Recent Events
- 27 Apr 2024 Immunogenicity and adverse event data from a preclinical trial in Influenza virus infections released by Longhorn Vaccines and Diagnostics
- 17 Oct 2023 Immunogenicity data from a preclinical study in Influenza virus infections released by Longhorn Vaccines and Diagnostics
- 29 Sep 2023 Interim safety and pharmacodynamics data from a preclinical studies in Influenza virus infections released by Longhorn Vaccines and Diagnostics